Other pages about the topic: Forecasting & Research

Participant Statistical Areas Program (PSAP) - 2020 Census

This program offers federally recognized tribes, state tribal liaisons, local governments, councils of government, and regional planning organizations the opportunity to review and modify select statistical boundaries that the Census Bureau uses to report the data that they collect. Registration will be March-May 2018. The work will be completed January-July 2019.

What are the affected geographies?

Local Update of Census Addresses (LUCA)

The Local Update of Census Addresses operation or LUCA, is a voluntary decennial census operation. LUCA is the only opportunity prior to the 2020 Census for tribal, state, and local governments to review and update the U.S. Census Bureau’s residential address list and flag group quarters for their jurisdiction.

Counting people experiencing homelessness during the 2020 Census

The intent of the 2020 Census is to count everyone living in the United States, including people experiencing homelessness or living in transitory locations. General information about how the homeless will be counted and categorized in the 2020 Census results is provided below, as well as references to more detailed explanations.

Hard-to-count population - 2020 Census

Understand the typology of hard-to-count (HTC)

In every census, there are certain socioeconomic and demographic factors that include age, housing status, and language that can influence self-response. The traditional socioeconomic and demographic factors that have tended to correlate with lower levels of self-response have included:

Recommendations on prescription drug price transparency legislation

In 2001, prescription drug costs represented 13 percent of the health care cost for an average American family; by 2017, those costs had grown to 17 percent. Given prescription drugs’ burgeoning share of health care costs — and the collective outrage over inexplicable price hikes highlighted recently in various media reports — concerns over prescription drug prices have been mounting. Absent any federal initiatives, states are now exploring options to address these rising prices.

Pages